Kimberly A. Veenstra
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Kimberly A. Veenstra has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Christopher John Secombes
Scottish Fish Immunology Research Centre, School of Biological Sciences, University of Aberdeen, Aberdeen AB24 2TZ, UK
2 shared publications - Juliette Ben Arous
SEPPIC, 22 Terrasse Bellini, Paris La Défense, 92806 Puteaux, France
2 shared publications - Lincoln Tubbs
Elanco Canada Ltd, Aquaculture Research and Development, P.O. Box 17, Victoria PE, C0A 2G0, Canada
2 shared publications - Ayham Alnabulsi
Vertebrate Antibodies Ltd., Zoology Building, Tillydrone Avenue, Aberdeen, AB24 2TZ, UK
1 shared publication C.J. Secombes
Univ Aberdeen, Scottish Fish Immunol Res Ctr, Inst Biol & Environm Sci, Tillydrone Ave, Aberdeen AB24 2TZ, Scotland
1 shared publicationG. Ionkoff
SEPPIC SA, Paris La Def 50 Blvd Natl,CS 90020, F-92257 La Garenne, France
1 shared publication
Latest Publications
- Open Access
Cellular Immune Responses in Rainbow Trout (Onchorhynchus mykiss) Following Vaccination and Challenge Against Salmonid Alphavirus (SAV)
Viral disease outbreaks remain a significant limiting factor for aquaculture. The majority of licensed vaccines used in the industry are administered as oil-adjuvanted formulations carrying inactivated whole pathogens. Cell-mediated immune responses, in particular those based on virus-specific cytotoxic T-cells (CTLs) to conventional inactivated oil-based vaccines, are largely unexplored. As vaccines cannot be optimized against viral pathogens if knowledge of host cellular immune mechanisms remains unknown, in this study we examined fundamental cell-mediated immune responses after vaccination of rainbow trout with an oil-adjuvanted inactivated vaccine against salmonid alphavirus (SAV) and after infection with SAV. A unique in vitro model system was developed to examine MHC class I restricted CTL responses in a clonal line of rainbow trout. The levels of cell-mediated cytotoxicity were compared to pathology, virus load, specific antibody response, changes in immune cell populations, and mRNA expression. Our results hint that different protective mechanisms are being triggered by infection compared to vaccination. While vaccination itself did not cause a strong cytotoxic or humoral response, subsequent challenge of vaccinated fish resulted in significantly stronger and faster specific cytotoxicity, alongside reduced viral titers and pathology. Hence, testing a vaccine on the capacity to induce cell-mediated cytotoxicity will still require a challenge test. Examination of cellular markers additionally indicates that the initial innate response induced by the vaccine could play an important role in steering adaptive mechanisms.
Open AccessCellular Immune Responses in Rainbow Trout (Onchorhynchus mykiss) Following Vaccination and Challenge Against Salmonid Alphavirus (SAV)
Viral disease outbreaks remain a significant limiting factor for aquaculture. The majority of licensed vaccines used in the industry are administered as oil-adjuvanted formulations carrying inactivated whole pathogens. Cell-mediated immune responses, in particular those based on virus-specific cytotoxic T-cells (CTLs) to conventional inactivated oil-based vaccines, are largely unexplored. As vaccines cannot be optimized against viral pathogens if knowledge of host cellular immune mechanisms remains unknown, in this study we examined fundamental cell-mediated immune responses after vaccination of rainbow trout with an oil-adjuvanted inactivated vaccine against salmonid alphavirus (SAV) and after infection with SAV. A unique in vitro model system was developed to examine MHC class I restricted CTL responses in a clonal line of rainbow trout. The levels of cell-mediated cytotoxicity were compared to pathology, virus load, specific antibody response, changes in immune cell populations, and mRNA expression. Our results hint that different protective mechanisms are being triggered by infection compared to vaccination. While vaccination itself did not cause a strong cytotoxic or humoral response, subsequent challenge of vaccinated fish resulted in significantly stronger and faster specific cytotoxicity, alongside reduced viral titers and pathology. Hence, testing a vaccine on the capacity to induce cell-mediated cytotoxicity will still require a challenge test. Examination of cellular markers additionally indicates that the initial innate response induced by the vaccine could play an important role in steering adaptive mechanisms.
- 1 August 2019
- Published by Elsevier in Fish & Shellfish Immunology
- Vol. 91, 452-453
Formulation of A. salmonicida adjuvanted vaccine for rainbow trout : Impact of the adjuvant oil origin
- 1 August 2019
- Published by Elsevier in Fish & Shellfish Immunology
- Vol. 91, 452-453
Formulation of A. salmonicida adjuvanted vaccine for rainbow trout : Impact of the adjuvant oil origin
- 5 February 2019
- Published by Elsevier in Fish & Shellfish Immunology
- Vol. 87, 559-564
Immunohistochemical examination of immune cells in adipose tissue of rainbow trout (Oncorhynchus mykiss) following intraperitoneal vaccination
- 5 February 2019
- Published by Elsevier in Fish & Shellfish Immunology
- Vol. 87, 559-564
Immunohistochemical examination of immune cells in adipose tissue of rainbow trout (Oncorhynchus mykiss) following intraperitoneal vaccination